Aurora Cannabis (ACB) Depreciation & Amortization (CF) (2017 - 2025)

Aurora Cannabis (ACB) reported Depreciation & Amortization (CF) of $4.1 million for Q1 2025, down 44.51% year-over-year from $7.3 million in Q1 2024, and up 7.17% quarter-over-quarter from $3.8 million in Q4 2024.

Aurora Cannabis (ACB) Depreciation & Amortization (CF) (2017 - 2025) Analysis & Trends

Aurora Cannabis (ACB) has 9 years of Depreciation & Amortization (CF) data on file, last reported at $4.1 million in Q1 2025.

  • Depreciation & Amortization (CF) for Q1 2025 came in at $4.1 million, down 44.51% year-over-year; the trailing twelve-month figure through Dec 2025 was $4.1 million (down 78.62% YoY), and the FY2025 annual result was $2.6 million, down 6.09% from the prior year.
  • Depreciation & Amortization (CF) grew to $4.1 million in Q1 2025 per ACB's latest filing, from $3.8 million in the prior quarter.
  • Over five years, Depreciation & Amortization (CF) peaked at $24.6 million in Q2 2021 and troughed at $3.8 million in Q3 2024.
  • A 5-year average of $8.5 million and a median of $7.2 million in 2022 frame the typical range for Depreciation & Amortization (CF).
  • The sharpest annual moves came in 2021 and 2022: Depreciation & Amortization (CF) jumped 103.82% in 2021, then tumbled 59.76% in 2022.
  • A 5-year view of Depreciation & Amortization (CF) shows it stood at $14.0 million in 2021, then slumped by 39.52% to $8.5 million in 2022, then plunged by 35.15% to $5.5 million in 2023, then plunged by 30.7% to $3.8 million in 2024, then rose by 7.17% to $4.1 million in 2025.
  • Business Quant data shows ACB's Depreciation & Amortization (CF) at $4.1 million in Q1 2025, $3.8 million in Q4 2024, and $3.8 million in Q3 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 239.00 Mn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn 119.00 Mn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 22.60 Mn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn 7.20 Mn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn 172.00 Mn
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn 19.43 Mn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn 22.68 Mn
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn 21.95 Mn
10 Liquidia 5.63 Bn 5.40 Bn 121.79 Mn 497,000.00

Historic Data

Download Data
DateValue
Mar 31, 2025 4.07 Mn
Mar 31, 2025 4.07 Mn
Dec 31, 2024 3.80 Mn
Dec 31, 2024 3.80 Mn
Sep 30, 2024 3.79 Mn
Sep 30, 2024 3.79 Mn
Jun 30, 2024 4.12 Mn
Jun 30, 2024 4.12 Mn
Mar 31, 2024 7.34 Mn
Mar 31, 2024 7.34 Mn
Dec 31, 2023 5.48 Mn
Dec 31, 2023 5.48 Mn
Sep 30, 2023 5.41 Mn
Sep 30, 2023 5.41 Mn
Dec 31, 2022 8.45 Mn
Dec 31, 2022 8.45 Mn
Sep 30, 2022 7.16 Mn
Sep 30, 2022 7.16 Mn
Jun 30, 2022 9.91 Mn
Jun 30, 2022 9.91 Mn